Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The significance of histology in non-small cell lung cancer.

× No keyword cloud information.

7 in total

1. Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: first results.

Authors: U Gatzemeier; A Schneider; J von Pawel
Journal: J Cancer Res Clin Oncol Date: 1995 Impact factor: 4.553

2. Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.

Authors: Hitoshi Ishikawa; Yuko Nakayama; Yoshizumi Kitamoto; Tetsuo Nonaka; Hidemasa Kawamura; Katsuyuki Shirai; Hideyuki Sakurai; Kazushige Hayakawa; Hideo Niibe; Takashi Nakano
Journal: Lung Date: 2006-11-03 Impact factor: 2.584

Review 3. The state of the art for artificial intelligence in lung digital pathology.

Authors: Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal: J Pathol Date: 2022-06-20 Impact factor: 9.883

4. Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.

Authors: Julia Kravchenko; Igor Akushevich; Amy P Abernethy; H Kim Lyerly
Journal: PLoS One Date: 2012-05-22 Impact factor: 3.240

The significance of histology in non-small cell lung cancer.

1. Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: first results.

2. Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.

Review 3. The state of the art for artificial intelligence in lung digital pathology.

4. Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.

5. 'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)

6. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis.

7. Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.